ProAssurance (PRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

08.11.24 03:00 Uhr

Werte in diesem Artikel
Aktien

16,20 EUR 0,80 EUR 5,19%

Indizes

935,5 PKT -8,9 PKT -0,94%

ProAssurance (PRA) reported $278.23 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 0.1%. EPS of $0.34 for the same period compares to -$0.07 a year ago.The reported revenue represents a surprise of +2.77% over the Zacks Consensus Estimate of $270.75 million. With the consensus EPS estimate being $0.12, the EPS surprise was +183.33%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how ProAssurance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Loss Ratio: 72.5% compared to the 80.1% average estimate based on five analysts. Underwriting Expense Ratio: 33.1% versus the five-analyst average estimate of 32.8%. Combined Ratio: 105.6% versus 112.9% estimated by five analysts on average. Net Loss Ratio - Workers Compensation: 77% versus 83.3% estimated by three analysts on average. Net premiums earned: $243.16 million versus the five-analyst average estimate of $231.29 million. The reported number represents a year-over-year change of +0.3%. Net investment income: $37.27 million versus the five-analyst average estimate of $36.63 million. The reported number represents a year-over-year change of +13.8%. Equity in earnings (loss) of unconsolidated subsidiaries: $4.77 million versus $3.71 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -7914.8% change. Other income(loss): -$2.20 million versus $2.82 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -165.9% change. Net Premiums Earned- Specialty Property & Casualty: $188.70 million versus the three-analyst average estimate of $185.52 million. The reported number represents a year-over-year change of -3.6%. Net Premiums Earned- Segregated Portfolio Cell Reinsurance: $12.63 million compared to the $11.43 million average estimate based on three analysts. The reported number represents a change of +86.7% year over year. Net Premiums Earned- Workers Compensation: $41.83 million versus the three-analyst average estimate of $40.23 million. The reported number represents a year-over-year change of +4.9%. Net investment income- Segregated Portfolio Cell Reinsurance: $1.01 million compared to the $0.87 million average estimate based on two analysts. The reported number represents a change of +67.9% year over year. View all Key Company Metrics for ProAssurance here>>>Shares of ProAssurance have returned +13.6% over the past month versus the Zacks S&P 500 composite's +3.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ProAssurance Corporation (PRA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf ProAssurance

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf ProAssurance

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu ProAssurance Corp.

Analysen zu ProAssurance Corp.

DatumRatingAnalyst
26.08.2005Update ProAssurance Corp.: OutperformKeefe Bruyette
DatumRatingAnalyst
26.08.2005Update ProAssurance Corp.: OutperformKeefe Bruyette
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für ProAssurance Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"